You just read:

Orexigen Therapeutics Announces Expansion of Distributorship Agreement with Biologix FZCO for Contrave® (naltrexone HCl / bupropion HCl extended release) to Egypt

News provided by

Orexigen Therapeutics, Inc.

Jul 26, 2017, 08:50 ET